Jurnal Reading Current Concept in The Management of Necrotizing Fasciitis

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 39

JURNAL READING

Current Concept in the Management


Of Necrotizing Fasciitis
Evangelos P. Misiakos*, George Bagias, Paul Patapis, Dimitrios Sotiropoulos,
Prodromos Kanavidis and Anastasios Machairas

Oleh:
Agus Darmanto I11108067
Erlin Irawati I11109059
Rakhmiana I11109004
Pembimbing:
dr. Zainul Naim, Sp.B

www.frontiersin.org September 2014 | Volume 1 |


Article 36

INTRODUCTION

Necrotiz

Early diagnosis is
mandatory, any
delay could prove
fatal :
- extensive
surgery
- higher rates of
amputation
- higher mortality
rates
- lead to (SIRS).

EPIDEMIOLOGY

ETIOLOGI
Trauma

ETIOLOGI
Fourniers gangrene

CO-MORBIDITIES AND RISK FACTOR


Comorbidities

PATHOPHYSIOLOGY

PATHOPHYSIOLOGY

PATHOPHYSIOLOGY
The extension of the infection and
necrosis is facilitated by the synergy
between the different bacteria and
toxins and the enzymes they produce
An anaerobic environment promotes
growth of anaerobic bacteria.
Gas formed by anaerobic bacteria
may lead to crepitus.

MICROBIOLOGY

DIAGNOSIS
CLINICAL SIGNS AND SYMPTOMS
BEDSIDE AND LABORATORY TESTS
IMAGING TEST

CLINICAL SIGNS AND


SYMPTOMS

CLINICAL SIGNS AND


SYMPTOMS

FULMINANT FORM
- Early sign are

CLINICAL SIGNS AND


SYMPTOMS

SUBACUTE FORM has a relatively slow clinical


course, which may endure for days or weeks.
Early phase

CLINICAL SIGNS AND


SYMPTOMS
The infection develops

BEDSIDE AND LABORATORY TESTS

Leukocytosis (WBC count in excess of


20,000/L is highly suspect).
Blood urea nitrogen >18 mg/dL and
serum creatinine >1.2 mg/dL reflect
ongoing renal failure, which is typically
present in these patients.
Serum creatine kinase is also elevated
(CK) inpatients with severe sepsis and
MODS

BEDSIDE AND LABORATORY TESTS


LRINEC scoring system for early
diagnosis
The finger test and frozen section
biopsycomplementary
Surgical explorations
Imaging (plain radiography, CT scan,
MRI, combination
USG) showing
The
ofgas formtion

BEDSIDE AND LABORATORY TESTS

IMAGING

Plain radiography showing gas


formation in soft tissue
CT Scan & MRI show the extent of
tissue infection, fascial swelling,
inflammation, and gas formation
USGhyperechoic foci with
reverberation artifact and dirty
shadowing at the site of infection,
representing the subcutaneous gas

TREATMENT
ANTIBIOTIC TREATMENT
SURGICAL MANAGEMENT
USE OF VACUUM-ASSISTED
CLOSURE DEVICE

ANTIBIOTIC TREATMENT

TYPE 1 INFECTION
Antibiotic treatment of a polymicrobial infection
should be based on history, Gram stain, and
culture.
Initial
treatment
includes
ampicillin
or
ampicillinsulbactam
combined
with
metronidazole or clindamycin .
Anaerobic coverage is quite important for type 1
infection:
metronidazole,
clindamycin,
or
carbapenems
(imipenem)
are
effective
antimicrobials.

ANTIBIOTIC TREATMENT

TYPE 2
Antibiotics against S. pyogenes and S.
Aureus first or second generation of
cephalosporins (MSSA)
MRSA vancomycin or daptomycin and
linezolid in cases where S. aureus is
resistant to vancomycin.

ANTIBIOTIC TREATMENT

TYPE 3
Clindamycin and penicillin Clostridium
species
If Vibrioinfection is suspected, the early
use
of
tetracyclines
(including
doxycycline and minocycline)and thirdgeneration cephalosporins is crucial for
the survival of the patient.
TYPE 4
Amphotericin B or fluoroconazoles.

ANTIBIOTIC TREATMENT
Antibiotics should be administered for
up to 5 days after local signs and
symptoms have resolved.
The mean duration of antibiotic
therapy for NF is 46 weeks.

SURGICAL MANAGEMENT

Emergency surgical debridement of


the affected tissues is the primary
management modality for NF.
Surgical debridement, necrosectomy,
and fasciotomy are the main aspects of
surgical treatment.

SURGICAL MANAGEMENT

Surgical management is indicated


especially for patients displaying intense
pain and skin color change, such as
edema and/or ecchymoses, or signs of
skin ischemia with blisters and bullae.
Patients must be operated on urgently
when they present with altered mental
status, hypotension, an elevated band
formed in the differential WBC count, and
metabolic acidosis.

SURGICAL MANAGEMENT

Patients with NF should be closely


monitored during the next 24 h; surgical
wounds and tissue viability should be
checked.
Complicated surgical wounds command
a second-look operation with radical
surgical debridement. Patients with NF
can require from 5 up to 40 additional
operations

SURGICAL MANAGEMENT

The extent of tissue extracted depends on


the body region, which is infected.
As a general rule, debridement will extend
until healthy tissue is found, though some
authors recommend that excision should be
limited to the edges of infection .
The general consensus is that careful
trimming of the potentially salvageable soft
tissue is also required (while non-infected
skin remains unattached)

SURGICAL MANAGEMENT

Nutritional support is required from the


first day of the patients admission to
hospital (preferably the ICU), to replace
lost proteins and fluid from large wounds
and/or the resultant toxic shock.
Metabolic demands are similar to those
of other major trauma or burns, which
means that the patient needs twice the
basic caloric requirements.

USE OF VACUUM-ASSISTED CLOSURE


DEVICE

Used for fast and effective wound closure.


A VAC device consists of a sterile, open-cell foam
sponge that is placed in the wound, the size of which
is adjusted to the wound size.This is covered with a
transparent adhesive drape to create an air- tight
environment.
The sponge is connected to a portablevacuum pump
bymeans of non-collapsible tubing. Evacuation is
applied to the sponge using the pump, which
provides continuous negative pressure.
TheVAC device improves wound healing by providing
microstrain.

USE OF VACUUM-ASSISTED CLOSURE


DEVICE

FUTURE THERAPIES

A study by Anaya et al. highlighted the


role of IVIG.
The authors concluded that the use of
IVIG seemed rational in patients with
groupA streptococcal infection who
developed streptococcal toxic shock
syndrome and in those with a high
mortality
risk
(advanced
age,
hypotension, and bacteremia).

FUTURE THERAPIES

StudybyLuetal. Showed that kallistatin,


originally found to be a tissue kallikreinbinding protein, can increase the survival
of group A streptococcus infected mice.
The
researchers
concluded
that
kallistatin significantly increased the
survival rate of GAS-infected mice, and
also reduced local skin damage and
bacterial counts.

THANK YOU

You might also like